A blood test that measures how quickly tumor cells divide could in the future help doctors assess prognosis and select treatment strategies for patients with melanoma that has spread to other parts of the body. This is shown in a study involving researchers from Karolinska Institutet, published in the journal Clinical Cancer Research.
If you liked the article, do not forget to share it with your friends. Follow us on Google News too, click on the star and choose us from your favorites.
If you want to read more Like this articles, you can visit our Science category.